Opill
Product
HRA Pharma
Total Payments
$1.2M
Transactions
38
Doctors
15
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $50,829 | 11 | 6 |
| 2023 | $2,859 | 1 | 0 |
| 2020 | $1.1M | 25 | 9 |
| 2017 | $20,239 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $701,478 | 11 | 58.2% |
| Consulting Fee | $299,564 | 16 | 24.8% |
| Unspecified | $180,040 | 7 | 14.9% |
| Travel and Lodging | $24,422 | 4 | 2.0% |
Payments by Type
General
$1.0M
31 transactions
Research
$180,040
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Adherence with continuous-dose oral | HRA Pharma | $156,968 | 2 |
| Adherence with continuous-use oral | HRA Pharma | $14,833 | 3 |
| Adherence with continuous use oral | HRA Pharma | $8,240 | 2 |
Top Doctors Receiving Payments for Opill
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Portland, OR | $654,832 | 3 |
| , MD | Obstetrics & Gynecology | Philadelphia, PA | $308,803 | 16 |
| , M.D | Obstetrics & Gynecology | Los Angeles, CA | $137,200 | 1 |
| , MD | Family Medicine | Phoenix, AZ | $19,768 | 1 |
| , D.O | Obstetrics & Gynecology | Rochester, NY | $17,750 | 3 |
| , MD | Obstetrics & Gynecology | Red Hook, NY | $14,124 | 4 |
| , PA | Medical | Clarence Center, NY | $12,350 | 1 |
| , M.D | Obstetrics & Gynecology | New York, NY | $11,000 | 1 |
| , M.D | Obstetrics & Gynecology | Royal Oak, MI | $6,505 | 1 |
| , MD | Pediatrics | Bronx, NY | $6,128 | 1 |
| , DO | Emergency Medicine | Dallas, TX | $5,750 | 1 |
| , M.D | Obstetrics & Gynecology | Portland, OR | $4,250 | 1 |
| , M.D | Obstetrics & Gynecology | Los Angeles, CA | $3,990 | 1 |
| , MD | Family Medicine | Cerritos, CA | $2,200 | 1 |
| , ARNP | Women's Health | Scottsdale, AZ | $555.00 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Scottsdale, AZ | $300.00 | 1 |
Ad
Manufacturing Companies
- HRA Pharma $1.2M
- Perrigo Company plc $50,829
Product Information
- Type Product
- Total Payments $1.2M
- Total Doctors 15
- Transactions 38
About Opill
Opill is a product associated with $1.2M in payments to 15 healthcare providers, recorded across 38 transactions in the CMS Open Payments database. The primary manufacturer is HRA Pharma.
Payment data is available from 2017 to 2024. In 2024, $50,829 was paid across 11 transactions to 6 doctors.
The most common payment nature for Opill is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($701,478, 58.2% of total).
Opill is associated with 3 research studies, including "Adherence with continuous-dose oral" ($156,968).